Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

DelveInsight's IBAT Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

The viral vector vaccines market, driven by innovation and global demand, offers expanding opportunities in immunization, notably for diseases like C ...

Cambridge based drug sleuth Bicycle Therapeutics has extended its cash runway from mid-2027 into 2028 as it closes in on ...

GlaxoSmithKline Pharmaceuticals' shares fell by 2% in Thursday's morning trade, reflecting a bearish market sentiment. The company is currently trading at Rs 2,680.10 per share.

Get comprehensive insights into the Uncomplicated Urinary Tract Infections (UTIs) pipeline with this 2025 report. It details 4+ companies and 5+ pipeline drugs, covering drug profiles, therapeutic ...

The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a strong pipeline of clinical trials, and ...